A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting

Completed

Conditions studied: Gram-Negative Bacterial Infections

In brief

This study is a retrospective, observational study to evaluate minocycline use in participants under real world conditions.

Key facts

Study ID
NCT03160040
Run by
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
People needed
71
Starts
2017-10-11
Expected to finish
2018-05-01
Last updated by the study team
2023-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.